More patients reach glycaemic control with a fixed-ratio combination of insulin glargine and lixisenatide (iGlarLixi) than with basal insulin at 12 weeks of treatment: A post hoc time-to-control analysis of LixiLan-O and LixiLan-L

Type 2 Diabetes Patients Reach Target Glycemic Control Faster Using IDegLira than Either Insulin Degludec or Liraglutide Given Alone

(2016) Tina Vilsbøll et al.   CLINICAL DRUG INVESTIGATION

Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial

(2016) Julio Rosenstock et al.   DIABETES CARE

Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial

(2016) Vanita R. Aroda et al.   DIABETES CARE

Addition of or switch to insulin therapy in people treated with glucagon-like peptide-1 receptor agonists: A real-world study in 66 583 patients

(2016) Olga Montvida et al.   DIABETES OBESITY & METABOLISM

Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin

(2016) K. Khunti et al.   DIABETES OBESITY & METABOLISM

Glycemic Exposure, Glycemic Control, and Metabolic Karma in Diabetic Complications

(2014) Merlin C. Thomas   ADVANCES IN CHRONIC KIDNEY DISEASE

Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with type 2 diabetes

(2014) Stephen C L Gough et al.   Lancet Diabetes & Endocrinology

Optimization of insulin therapy in patients with Type 2 diabetes mellitus: beyond basal insulin

(2012) B. T. Blak et al.   DIABETIC MEDICINE

GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus

(2012) Juris J. Meier   Nature Reviews Endocrinology

10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes

(2008) Rury R. Holman et al.   NEW ENGLAND JOURNAL OF MEDICINE